Ronald B. Moss is Chief Medical Officer of Adamis Pharmaceuticals Corp. Currently has a direct ownership of 201,911 shares of ADMP, which is worth approximately $98,936. The most recent transaction as insider was on Mar 18, 2022, when has been sold 8,199 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $4,919. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202K
0% 3M change
0% 12M change
Total Value Held $98,936

Ronald B. Moss Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2022
SELL
Open market or private sale
$4,919 $0.6 p/Share
8,199 Reduced 3.9%
201,911 Common Stock
Dec 01 2021
SELL
Open market or private sale
$27,731 $0.78 p/Share
35,553 Reduced 14.47%
210,110 Common Stock
Feb 21 2021
BUY
Exercise of conversion of derivative security
-
13,911 Added 5.36%
245,663 Common Stock
Nov 18 2020
SELL
Open market or private sale
$3,498 $0.41 p/Share
8,532 Reduced 3.55%
231,752 Common Stock
RBM

Ronald B. Moss

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on ADMP

Follow Adamis Pharmaceuticals Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMP shares.

Notify only if

Insider Trading

Get notified when an Adamis Pharmaceuticals Corp insider buys or sells ADMP shares.

Notify only if

News

Receive news related to Adamis Pharmaceuticals Corp

Track Activities on ADMP